South Africa: SAHPRA Approves Lenacapavir for HIV Prevention
South Africa Approves Lenacapavir for HIV Prevention South Africa's Health Product Regulatory Authority (SAHPRA) has approved lenacapavir, a twice-yearly HIV prevention drug. The dr…
South Africa Approves Lenacapavir for HIV Prevention South Africa's Health Product Regulatory Authority (SAHPRA) has approved lenacapavir, a twice-yearly HIV prevention drug. The dr…
Utah's Olympic Organizers in NYC Leaders of Utah's 2034 Winter Games are attending the U.S. Olympic and Paralympic Committee Team USA Medi…
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of N…
Scientists Say This 5-Minute Trick Could Help You Live Longer New research suggests it could be the key to boosting heart and lung health.…
Bird Flu Strain H9N2: A Potential Threat to Humans A team of scientists has raised concerns about the H9N2 bird flu virus, which has adapt…
Waaree Secures 692MW Solar Module Deals Waaree Energies, an Indian solar manufacturer, has secured four solar module supply contracts tota…
Ericsson and Nokia Collaborate on 6G Video Research Nokia, Ericsson, and the Fraunhofer Heinrich Hertz Institute have presented a proof-of…
Trump Rejects Vice Presidential Run Donald Trump has ruled out running for vice president in the 2028 American election. Aboard Air…
Vesper Solar 600 MW Texas Project The Vesper Solar 600 MW Texas project demonstrates how an agrivoltaics mindset can unlock prime sites fo…
Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been confirmed, with 40 ties s…
Insurance: Protecting Against AI’s Dark Side Executives face AI-driven cyber threats. Insurers, reinsurers, and corporates are navigating …